Please select a Capability in order to start your service request.
Learn about the dangers of hazardous drug exposure―they are studied, documented and very real
About 8 million U.S. healthcare workers, including pharmacists, physicians and other caregivers, are potentially exposed to hazardous drugs, according to the CDC.1 This exposure is putting them at risk of both short- and long-term health issues such as headaches, hair loss, nausea, organ damage, reproductive problems,2 developmental impairment, genetic issues and even cancer.3
To address these risks, healthcare facilities need to comply with new and existing standards, guidelines and recommendations. With upcoming changes driven by USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings, facilities should use a closed system drug transfer device (CSTD) when compounding hazardous drugs when the dosage form allows, and CSTDs must be used when administering antineoplastic hazardous drugs when the dosage form allows.4
When selecting a CSTD solution, you need to protect your team. But we know that is not your only concern. With the BD PhaSeal™ system, the Texium™ system and an array of services—all designed to help you reduce the risk of hazardous drug exposure, you can obtain a tailored solution that balances your needs for safety, efficiency and cost.
†Surfaces with contamination at or above the limits of detection have 95% specificity and sensitivity
††For a select number of hazardous drugs: Methotrexate, doxorubicin and cyclophosphamide